Radiological diagnosis of pulmonary mucormycosis
https://doi.org/10.24835/1607-0763-2018-5-45-54
Abstract
Pulmonary mucormycosis is a rare opportunistic fungal infection, caused by Zygomycetes, order Mucorales. Poorly controlled diabetes mellitus and neutropenia are main risk factors. In recent years, the incidence of mucormycosis is increasing, due to widespread use of aggressive chemotherapy, including schemes for elder patients and increasing amount of stem cell transplantation. The disease is characterised by severe course, rapid spread and high mortality rates. Radiological diagnostics is first line methods in detecting infectious process in patients. Detecting specific features helps physician in early diagnosis and improve outcome of disease.
About the Authors
A. B. Kosichkina
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
Russian Federation
radiologist at the Department of Radiology, junior researcher at the Department of Diagnostic and interventional radiology
197758, Pesochny, Leningrad region, Leningradskaya str., 68
A. V. Mishchenko
N.N. Petrov National Medical Research Center of Oncology
St. Petersburg State University
Russian Federation
Russian Federation
doct. of med. sci., Head of the Department of Diagnostic and Interventional radiology
Professor of the Scientific Clinical and Educational Center “Radiation Diagnostics and Nuclear Medicine”
S. A. Kuleva
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
Russian Federation
doct. of med. sci., Head of the Department of Chemotherapy and combined treatment of pediatric malignancies, lead researcher at the Department of innovative methods of therapeutic oncology and rehabilitation
I. A. Burovik
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
Russian Federation
cand. of med. sci., radiologist at the Department of Radiology, senior researcher at the Department of Diagnostic and interventional radiology
A. S. Artemeva
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
cand. of med. sci., Head of the Department of Pathology, Head of the Laboratory of the tumor morphology
Russian Federation
cand. of med. sci., Head of the Department of Pathology, Head of the Laboratory of the tumor morphology
A. S. Petrova
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
radiologist at the Department of Radiology
Russian Federation
radiologist at the Department of Radiology
S. A. Gharibyan
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
resident at the Department of Radiology
Russian Federation
resident at the Department of Radiology
N. V. Boiko
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
radiologist at the Department of Radiology
Russian Federation
radiologist at the Department of Radiology
K. S. Kozyreva
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
radiologist at the Department of Radiology
Russian Federation
radiologist at the Department of Radiology
P. S. Kalinin
N.N. Petrov National Medical Research Center of Oncology
Russian Federation
Russian Federation
cand. of med. sci., radiologist at the Department of Radiology, senior researcher at the Department of diagnostic and interventional Radiology
G. N. Dorovskikh
Krasnoyarsk state medical university named after Prof. V.F. Voyno-Yasenetsky
Omsk City Emergency Hospital №1
Russian Federation
Russian Federation
doct. of med. sci., Professor, Department of Radiology of Postgraduate Education
Head of the Department of Radiology
References
1. Araviyskiy R.A., Klimko N.N., Vasileva N.V. Diagnostics of Mycosis. SPb.: SPbMAPO, 2004. 185 p. (In Russian)
2. Ribes J.A., Vanover-Sams C.L., Baker D.J. Zygomycetes in human disease. Clin. Microbiol. Rev. 2000; 13: 236–301.
3. Khostelidi S.N. The Principal About Zygomycosis (Review). Problems of medical mycology. 2006; 8 (4): 8–18. (In Russian)
4. Thajeb P., Thajeb T., Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Scand. J. Infect. Dis. 2004; 36: 643–648.
5. Goodman & Rinaldi 1991, http://www.rusmedserv.com/mycology/index.html
6. Hibbett D.S., Binder M., Bischoff J.F., Blackwell M., Cannon P.F., Eriksson O.E., Huhndorf S., James T., Kirk P.M., Lücking R., Thorsten Lumbsch H., Lutzoni F., Matheny P.B., McLaughlin D.J., Powell M.J., Redhead S., Schoch C.L., Spatafora J.W., Stalpers J.A., Vilgalys R., Aime M.C., Aptroot A., Bauer R., Begerow D., Benny G.L., Castlebury L.A., Crous P.W., Dai Y.C., Gams W., Geiser D.M., Griffith G.W., Gueidan C., Hawksworth D.L., Hestmark G., Hosaka K., Humber R.A., Hyde K.D., Ironside J.E., Kõljalg U., Kurtzman C.P., Larsson K.H., Lichtwardt R., Longcore J., Miadlikowska J., Miller A., Moncalvo J.M., Mozley-Standridge S., Oberwinkler F., Parmasto E., Reeb V., Rogers J.D., Roux C., Ryvarden L., Sampaio J.P., Schüssler A., Sugiyama J., Thorn R.G., Tibell L., Untereiner W.A., Walker C., Wang Z., Weir A., Weiss M., White M.M., Winka K., Yao Y.J., Zhang N. A higher-level phylogenetic classification of the Fungi. Mycological Res. 2007; 111 (5): 509–547. DOI: 10.1016/j.mycres.2007.03.004.
7. Petrikkos G., Skiada A., Lortholary O., Roilides E., Walsh T.J., Kontoyiannis D.P.. Epidemiology and clinical manifestations of mucormycosis. Clin. Infect. Dis. 2012; 54, Suppl 1: S23–S34. DOI: 10.1093/cid/cir866.
8. Bourcier J., Heudes P.M., Morio F., Gastinne T., Chevallier P., Rialland-Battisti F., Garandeau C., Danner-Boucher I., Le Pape P., Frampas E., Moreau P., Defrance C., Peterlin P. Prevalence of the reversed halo sign in neutropenic patients compared with non- neutropenic patients: Data from a single – centre study involving 27 patients with pulmonary mucormycosis (2003–2016). Mycoses. 2017; 60 (8): 526–533. DOI: 10.1111/myc.12624.
9. Spellberg B., Ibrahim A. S. Recent advances in the treatment of mucormycosis. Curr. Infect. Dis. Rep. 2010; 12 (6): 423–429. DOI: 10.1007/s11908-010-0129-9.
10. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova T.A., Schaufele R.L., Sein M., Sein T., Chiou C.C., Chu J.H., Kontoyiannis D.P., Walsh T.J. Epidemiology and Outcome of Zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 2005; 41: 634–653. DOI: 10.1086/432579.
11. Klimko N.N. Mycoses: diagnosis and treatment. Moscow: Izdatel’stvo Vi Dzhi Grupp, 2008. 336 р. (In Russian)
12. Lin E., Moua T., Limper A.H. Pulmonary mucormycosis: clinical features and outcomes. Infection. 2017; 45 (4): 443–448. DOI: 10.1007/s15010-017-0991-6.
13. Gleissner B., Schilling A., Anagnostopolous I., Siehl I., Thiel E., Anagnostopolous I., et al. Improved outcome of zygomycosis in patients with hematological diseases? Leukemia Lymphoma. 2004; 45: 1351–1360.
14. Caillot D., Valot S., Lafon I., Basmaciyan L., Chretien M.L., Sautour M., Million L., Legouge C., Payssot A., Dalle F. Is it time to include CT “Reverse Halo Sign” and qPCR targeting mucorales in serum to EORTC-MSG criteria for the diagnosis of pulmonary mucormycosis in leukemia patients? Open forum infectious diseases. Oxford University Press. 2016; 3 (4): fw190. DOI: 10.1093/ofid/ofw190.
15. Millon L., Herbrecht R., Grenouillet F., Morio F., Alanio A., Letscher-Bru V., Cassaing S., Chouaki T., Kauffmann-Lacroix C., Poirier P., Toubas D., Augereau O., Rocchi S., Garcia-Hermoso D., Bretagne S.; French Mycosis Study Group. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin. Microbiol. Infect. 2016; 22: 810. e1–810. e8. DOI: 10.1016/j.cmi.2015.12.006.
16. Millon L., Larosa F., Lepiller Q., Legrand F., Rocchi S., Daguindau E., Scherer E., Bellanger A.P., Leroy J., Grenouillet F. Quantitative polymerase chain reaction detec tion of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin. Infect. Dis. 2013; 56 (10): e95–e101. DOI: 10.1093/cid/cit094.
17. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., Pappas P.G., Maertens J., Lortho lary O., Kauffman C.A., Denning D.W., Patterson T.F., Maschmeyer G., Bille J., Dismukes W.E., Herbrecht R., Hope W.W., Kibbler C.C., Kullberg B.J., Marr K.A., Muñoz P., Odds F.C., Perfect J.R., Restrepo A., Ruhnke M., Segal B.H., Sobel J.D., Sorrell T.C., Viscoli C., Wingard J.R., Zaoutis T., Bennett J.E.; European Organization for Research and Treatment of Cancer/Invasive Fungal-Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin. Infect. Dis. 2008; 46 (12): 1813–1821. DOI: 10.1086/588660.
18. Cornely O.A., Arikan-Akdagli S., Dannaoui E., Groll A.H., Lagrou K., Chakrabarti A., Lanternier F., Pagano L., Skiada A., Akova M., Arendrup M.C., Boekhout T., Chowdhary A., Cuenca-Estrella M., Freiberger T., Guinea J., Guarro J., de Hoog S., Hope W., Johnson E., Kathuria S., Lackner M., Lass-Flörl C., Lortholary O., Meis J.F., Meletiadis J., Muñoz P., Richardson M., Roilides E., Tortorano A.M., Ullmann A.J., van Diepeningen A., Verweij P., Petrikkos G.; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis. 2013; Clin. Microbiol. Infect. 2014; 20: 5–26. DOI: 10.1111/1469-0691.12371.
19. Chamilos G., Lewis R.E., Kontoyiannis D.P. Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin. Infect. Dis. 2008; 47 (4): 503–509. DOI: 10.1086/590004.
20. Cereser L., Zuiani C., Graziani G., Girometti R., Como G., Zaja F., Bazzocchi M. Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia. La Radiologia Medica. 2010; 115 (2): 205–214. DOI: 10.1007/s11547-009-0433-3.
21. Roy V., Ali L.I., Selby G.B. Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation. Am. J. Hematol. 2000; 64 (3): 170–174.
22. McAdams H.P., Rosado de Christenson M., Strollo D.C., Patz E.F. Jr. Pulmonary mucormycosis: radiologic findings in 32 cases. Am. J. Roentgenol. 1997; 168 (6): 1541–1548.
23. Hatrick A. G., Matson M. B., Bingham J. B. Invasive pulmonary mucormycosis with vascular involvement. Grand. Rounds. 2001; 2: 8–10. DOI: 10.1102/1470-5206.2001.0013.
24. Hammer M.M., Madan R., Hatabu H. Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time. Am. J. Roentgenol. 2018; 210 (4): 742–747. DOI: 10.2214/AJR.17.18792.
25. Da Nam B., Kim T.J., Lee K.S., Kim T.S., Han J., Chung M.J. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings. Eur. Radiol. 2018; 28 (2): 788–795. DOI: 10.1007/s00330-017-5007-5.
26. Georgiadou S.P., , Sipsas N.V., Marom E.M., Kontoyiannis D.P. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin. Infect. Dis. 2011; 52 (9): 1144–1155. DOI: 10.1093/cid/cir12.
27. Choo J.Y., Park C.M., Lee H.J., Lee C.H., Goo J.M., Im J.G. Sequential morphological changes in follow-up CT of pulmonary mucormycosis. Diagn. Intervent. Radiol. 2014; 20 (1): 42. DOI: 10.5152/dir.2013.13183.
28. Caillot D., Legouge C., Lafon I., Ferrant E., Pagès P.B., Plocque A., Estivalet L., Valot S., Dalle F., Abou Hanna H., Chretien M.L. Mucormycoses pulmonaires au cours des traitements de leucémies aiguës. Analyse rétrospective d’une série de 25 patients. Revue des Maladies Respiratoires. 2018. DOI: 10.1016/j.rmr.2017.11.009.
29. Voloudaki A.E., Bouros D.E., Froudarakis M.E., Datseris G.E., Apostolaki E.G., Gourtsoyiannis N.C. Crescentic and ring- shaped opacities. CT features in two cases of bronchiolitis obliterans organizing pneumonia (BOOP). Acta Radiol. 1996; 37: 889–892.
30. Godoy M.C.B., Viswanathan C., Marchiori E., Truong M.T., Benveniste M.F., Rossi S., Marom E.M. The reversed halo sign: update and differential diagnosis. Br. J. Radiol. 2012; 85: 1226–1235. DOI: 10.1259/bjr/54532316.
31. Rea G., Dalpiaz G., Vatrella A., Damiani S., Marchiori E. The reversed halo sign: also think about chronic eosinophilic pneumonia. J. Brasileiro de Pneumologia. 2017; 43 (4): 322–323. DOI: 10.1590/S1806-37562017000000077.
32. Marchiori E., Marom E.M., Zanetti G., Hochhegger B., Irion K.L., Godoy M.C.B. Reversed halo sign in invasive fungal infections: criteria for differentiation from organizing pneumonia. Chest J. 2012; 142: 1469. DOI: 10.1378/chest.12-0114.
33. Marchiori E., Hochhegger B., Zanetti G. Reversed halo sign in invasive fungal infections. Jornal Brasileiro de Pneumologia. 2016; 42 (3): 232–232. DOI: 10.1590/S1806-37562016000000119.
34. Marchiori E., Menna Barreto M., Pereira Freitas H.M., Hochhegger B., Soares Souza A Jr., Zanetti G., Dias Mançano A., Souza Rodrigues R. Morphological characteristics of the reversed halo sign that may strongly suggest pulmonary infarction. Clin. Radiol. 2018; 73 (5): 503. e7–503. e13. DOI: 10.1016/j.crad.2017.11.022.
35. Wahba H., Truong M.T., Lei X., Kontoyiannis D.P., Marom E.M. Reversed halo sign in invasive pulmonary fungal infections. Clin. Infect. Dis. 2008; 46: 1733–1737. DOI: 10.1086/587991.v.
36. Jung J., Kim M.Y., Lee H.J., Park Y.S., Lee S.O., Choi S.H., Kim Y.S., Woo J.H., Kim S.H. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis. Clin. Microbiol. Infect. 2015; 21 (7): 684. e11–684. e18. DOI: 10.1016/j.cmi.2015.03.019.
37. Legouge C., Caillot D., Chrétien M.L., Lafon I., Ferrant E., Audia S., Pagès P.B., Roques M., Estivalet L., Martin L., Maitre T., Bastie J.N., Dalle F. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin. Infect. Dis. 2013; 58 (5): 672–678. DOI: 10.1093/cid/cit929.
Review
For citations:
Kosichkina A.B., Mishchenko A.V., Kuleva S.A., Burovik I.A., Artemeva A.S., Petrova A.S., Gharibyan S.A., Boiko N.V., Kozyreva K.S., Kalinin P.S., Dorovskikh G.N. Radiological diagnosis of pulmonary mucormycosis. Medical Visualization. 2018;(5):45-54. (In Russ.) https://doi.org/10.24835/1607-0763-2018-5-45-54
Views:
1815
Email this article 